OTO-313 in Subjects With Unilateral Subjective Tinnitus

NCT04829214 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjective Tinnitus

Interventions

DRUG: OTO-313
DRUG: Placebo

Sponsor

Otonomy, Inc.